SharonAI Holdings Completes SPAC Merger, Announces $70M Asset Sale & $100M Convertible Note Financing Amidst Going Concern Doubts

summarizeSummary

SharonAI Holdings completed a SPAC merger, enacted a 1-for-50 reverse stock split, and delisted to OTC, while disclosing going concern doubts. The company is pursuing a $70M asset sale and a $100M convertible note financing to fund a strategic pivot to GPU-as-a-Service.

check_boxKey Events

• SPAC Merger Completed

  The Business Combination Agreement with Roth CH Acquisition Co. was consummated on December 17, 2025, with Pubco renamed SharonAI Holdings, Inc.

• 1-for-50 Reverse Stock Split

  A 1-for-50 reverse stock split was effective December 24, 2025, significantly reducing the number of outstanding shares and increasing the per-share price, often a sign of financial distress for low-priced stocks.

• Delisted from Nasdaq to OTC Markets

  The company voluntarily delisted its securities from Nasdaq on April 25, 2024, and now trades on the OTC Markets Group Pink Open Market under 'SHAZ' and 'SHAZW'.

• Sale of TCDC Joint Venture Interest for $70M

  SharonAI is selling its 50% interest in Texas Critical Data Centers LLC (TCDC) for an aggregate of $70 million, comprising $10M cash, $10M in NUAI stock, and a $50M senior secured convertible promissory note. This is a substantial divestment and capital infusion.

auto_awesomeAnalysis

SharonAI Holdings, Inc. has completed its SPAC merger and is undertaking significant, high-cost capital actions to address its precarious financial position, as evidenced by explicit going concern warnings. The company recently executed a 1-for-50 reverse stock split and delisted from Nasdaq to the OTC Markets, signaling severe financial distress. The announced sale of its 50% interest in Texas Critical Data Centers LLC for $70 million and a new convertible note financing of approximately $100 million (with potential for up to $200 million at 12-15% interest) are critical for its survival and planned pivot to GPU-as-a-Service. However, these large transactions, especially the expensive debt, highlight the urgent need for capital and the high-risk nature of the company's strategy. The warrants, with an exercise price of $575.00 against a current stock price of $1.85, are deeply out-of-the-money, making the potential $256 million from their exercise unrealistic.